Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

REID W MERRYMAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1568800605
CMS profile
1062651
Location
BOSTON, MA

General Payments · PY2019–2024

$264,758.57

  • Reported across 43 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$250,489.12

32 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Genentech, Inc. $225,000.00 15
Genmab U.S., Inc. $15,941.80 6
Kite Pharma, Inc. $4,361.73 3
Ipsen Biopharmaceuticals, Inc $3,480.00 1
ABBVIE INC. $996.71 3
E.R. Squibb & Sons, L.L.C. $667.16 2
Genentech USA, Inc. $21.51 1
ADC Therapeutics America, Inc. $20.21 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $105.00 1
PY2021 $3,500.00 1
PY2022 $8,045.42 5
PY2023 $2,619.03 4
PY2024 $250,489.12 32

Payment records · PY2024 (32)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $43.68 09/06/2024 Food and Beverage Undisputed 01/23/2026 1105025964 CMS
ABBVIE INC. $53.03 09/10/2024 Travel and Lodging Undisputed 01/23/2026 1105025966 CMS
ABBVIE INC. $900.00 09/19/2024 Consulting Fee Undisputed 01/23/2026 1105025968 CMS
ADC Therapeutics America, Inc. $20.21 02/02/2024 Food and Beverage Undisputed 01/23/2026 1121191931 CMS
E.R. Squibb & Sons, L.L.C. $333.58 01/02/2024 Travel and Lodging Undisputed 01/23/2026 1101313759 CMS
E.R. Squibb & Sons, L.L.C. $333.58 01/02/2024 Food and Beverage Undisputed 01/23/2026 1101313833 CMS
Genentech USA, Inc. $21.51 06/15/2024 Food and Beverage Undisputed 01/23/2026 1133095105 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095044 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095049 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095053 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095057 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095061 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095065 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095069 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095073 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095076 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095081 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095085 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095089 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095093 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095097 CMS
Genentech, Inc. $15,000.00 06/17/2024 Grant Undisputed 01/23/2026 1133095101 CMS
Genmab U.S., Inc. $971.90 06/12/2024 Travel and Lodging Undisputed 01/23/2026 1126831128 CMS
Genmab U.S., Inc. $10,638.60 06/12/2024 Travel and Lodging Undisputed 01/23/2026 1126831132 CMS
Genmab U.S., Inc. $26.89 06/12/2024 Travel and Lodging Undisputed 01/23/2026 1126831134 CMS
Genmab U.S., Inc. $16.92 06/13/2024 Travel and Lodging Undisputed 01/23/2026 1126831126 CMS
Genmab U.S., Inc. $29.99 06/13/2024 Travel and Lodging Undisputed 01/23/2026 1126831130 CMS
Genmab U.S., Inc. $4,257.50 06/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1126831136 CMS
Ipsen Biopharmaceuticals, Inc $3,480.00 10/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091993007 CMS
Kite Pharma, Inc. $108.69 09/04/2024 Food and Beverage Undisputed 01/23/2026 1128609301 CMS
Kite Pharma, Inc. $13.04 09/04/2024 Food and Beverage Undisputed 01/23/2026 1128609303 CMS
Kite Pharma, Inc. $4,240.00 09/12/2024 Consulting Fee Undisputed 01/23/2026 1128609305 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.